Royal Agrifirm Group, based in the Netherlands, has announced its acquisition of Hamlet Protein, a Danish producer specializing in soy-based protein ingredients designed for young animal nutrition.
The acquisition is anticipated to finalize in the coming weeks, pending typical closing conditions. Post-acquisition, Hamlet Protein will operate under its name while becoming part of Agrifirm. In a joint press release, both companies expressed intentions to leverage their strengths collaboratively to enhance innovative nutritional concepts for their valued clientele in the global feed market.
Corporate Profiles: Agrifirm and Hamlet Protein
Agrifirm, headquartered in Apeldoorn, Netherlands, employs nearly 3,000 professionals worldwide and boasts an impressive international network with subsidiaries in 14 countries. The company generated a turnover of €28.2 million in 2025.
On the other hand, Hamlet Protein, based in Horsens, Denmark, has a workforce of 115, operating production facilities in Denmark and the U.S., catering to customers globally.
Commitment to Animal Health
Commenting on the strategic alignment, Piet Hilarides, CEO of Agrifirm, stated, “This acquisition is perfectly in line with our mission. By integrating Hamlet Protein’s cutting-edge technology, we enhance our capability to advance optimal health and performance in animals throughout their life cycles, reflecting our commitment to establishing a sustainable food supply chain for future generations.”
Background of Hamlet Protein
Hamlet Protein is currently owned by Altor, a private equity firm that acquired the company in 2015 to drive its growth and solidify its position as a top-tier provider of soy-based specialty ingredients for young animals. Despite facing evolving market conditions and various external challenges, Hamlet has steadfastly advanced its product range and geographical outreach, cultivating a solid operational framework for future expansion while maintaining a robust focus on research and development.
Looking Ahead: Growth Opportunities
Erik Visser, CEO of Hamlet Protein, shared his enthusiasm about the partnership: “Aligning with Royal Agrifirm Group will enable us to expedite our growth trajectory, broaden our global footprint, and continue providing high-quality digestible solutions that support young animal health. This collaboration opens up exciting new avenues for both our customers and team members.”
